Amgen AMGN
NASDAQ AMGN
$465.67 -1.39 (-0.30%)
At close: Nov 13, 2026 · 4:00 PM EST

Amgen (AMGN) Short-Term Debt issuances (2011)

Updated

Amgen (AMGN) recorded Short-Term Debt issuances of $462 million in Q4 2011.

Analysis

Amgen (AMGN) Short-Term Debt issuances (2011) Analysis & Trends

For FY2011, Amgen reported Short-Term Debt issuances of $762 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 2.28 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Vertex Pharmaceuticals 136.55 Bn 104.28 Bn 2.91 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 462.00 Mn
API Access

Amgen Short-Term Debt issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=AMGN&period=max&api_key=YOUR_API_KEY